Stop using these cough syrups immediately, warns Telangana Drug Authority
- byDoctor News Daily Team
- 11 October, 2025
- 0 Comments
- 0 Mins

Telangana:The Drugs Control Administration, Telangana, has issued an urgent public alert advising citizens to immediately stop using two cough syrups found adulterated withDiethylene Glycol (DEG)—a highly toxic subtance. The alert follows a report from the Drug Testing Laboratory, Government of Madhya Pradesh, Bhopal, which detected the presence of DEG in the following syrups: 1. “Relife” Cough Syrup (Ambroxol Hydrochloride, Guaiphenesin, Terbutaline Sulphate & Menthol Syrup) o Batch No.: LSL25160 o Expiry Date: 12/2026 o Manufactured By: M/s. Shape Pharma Pvt. Ltd., Plot No. 4, Shekhpar – 363510, Gujarat 2. “Respifresh TR” Cough Syrup (Bromhexine Hydrochloride, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup) o Batch No.: R01GL2523 o Expiry Date: 12/2026 o Manufactured By: M/s. Rednex Pharmaceuticals Pvt. Ltd., Survey No. 586 & 231, Near SKF Bearing, Bavla–Bagodara N.H. 8A, Taluka Bavla, District Ahmedabad, Gujarat – 383220 Read also:MP Cough Syrup Case: Doctors' associations demand central probe, case withdrawal for arrested paediatrician The DCA has directed all Drugs Inspectors and Assistant Directors across Telangana to immediately alert retailers, distributors, and hospitals tofreeze stocksof the said product batches and ensure that the same are not dispensed or sold under any circumstances. Citizens in possession of these products have been urged to report them to the nearest Drugs Control Authority without delay or report possession of the said products directly to the Drugs Control Administration, Telangana. Read also:Cough syrup crisis: Tamil Nadu suspends 2 drug inspectors, moves to close pharma co "The Drugs Control Administration, Telangana, has initiated necessary enforcement measures and is actively monitoring the situation to prevent further risk to public health. The public is urged to exercise utmost caution and refrain from using the aforementioned products to avert any potential health hazards associated with Diethylene Glycol toxicity," the administration stated. Read also:SC to hear plea seeking CBI probe into cough syrup deaths on October 10
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
Karnataka's plan to set up new GMCs under PPP mode...
- 20 October, 2025
UP to set up 15 temporary hospitals for Ayodhya De...
- 20 October, 2025
Rajasthan HC issues contempt notices to state for...
- 20 October, 2025
Maha constitutes panel to draft policy on mental h...
- 20 October, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!